Results 1 to 10 of about 16,343,516 (183)

GSK-3 and Tau: A Key Duet in Alzheimer’s Disease [PDF]

open access: yesCells, 2021
Glycogen synthase kinase-3 (GSK-3) is a ubiquitously expressed serine/threonine kinase with a plethora of substrates. As a modulator of several cellular processes, GSK-3 has a central position in cell metabolism and signaling, with important roles both ...
Carmen Laura Sayas, Jesús Ávila
doaj   +3 more sources

The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment [PDF]

open access: yesCells, 2020
The serine/threonine kinase glycogen synthase kinase-3 (GSK-3) was initially identified because of its key role in the regulation of glycogen synthesis. However, it is now well-established that GSK-3 performs critical functions in many cellular processes,
Giuseppa Augello   +6 more
doaj   +3 more sources

Targeting the coronavirus nucleocapsid protein through GSK-3 inhibition. [PDF]

open access: yesProc Natl Acad Sci U S A, 2021
The coronaviruses responsible for severe acute respiratory syndrome (SARS-CoV), COVID-19 (SARS-CoV-2), Middle East respiratory syndrome (MERS-CoV), and other coronavirus infections express a nucleocapsid protein (N) that is essential for viral ...
Liu X   +18 more
europepmc   +4 more sources

Lithium and Therapeutic Targeting of GSK-3. [PDF]

open access: yesCells, 2021
Lithium salts have been in the therapeutic toolbox for better or worse since the 19th century, with purported benefit in gout, hangover, insomnia, and early suggestions that lithium improved psychiatric disorders.
Snitow ME, Bhansali RS, Klein PS.
europepmc   +2 more sources

Regulation of Autophagy by the Glycogen Synthase Kinase-3 (GSK-3) Signaling Pathway. [PDF]

open access: yesInt J Mol Sci, 2022
Autophagy is a vital cellular mechanism that benefits cellular maintenance and survival during cell stress. It can eliminate damaged or long-lived organelles and improperly folded proteins to maintain cellular homeostasis, development, and ...
Pan HY, Valapala M.
europepmc   +2 more sources

Pathobiology and Therapeutic Relevance of GSK-3 in Chronic Hematological Malignancies [PDF]

open access: yesCells, 2022
Glycogen synthase kinase-3 (GSK-3) is an evolutionarily conserved, ubiquitously expressed, multifunctional serine/threonine protein kinase involved in the regulation of a variety of physiological processes.
Alberto M. Martelli   +4 more
doaj   +2 more sources

Mechanisms and Therapeutic Implications of GSK-3 in Treating Neurodegeneration. [PDF]

open access: yesCells, 2021
Neurodegenerative disorders are spreading worldwide and are one of the greatest threats to public health. There is currently no adequate therapy for these disorders, and therefore there is an urgent need to accelerate the discovery and development of ...
Rippin I, Eldar-Finkelman H.
europepmc   +2 more sources

Antiproliferative and apoptotic effect of LY2090314, a GSK-3 inhibitor, in neuroblastoma in vitro

open access: yesBMC Cancer, 2018
Background Neuroblastoma (NB) is a devastating disease. Despite recent advances in the treatment of NB, about 60% of high-risk NB will have relapse and therefore long-term event free survival is very minimal.
Selvi Kunnimalaiyaan   +4 more
doaj   +2 more sources

Isoform-Specific Role of GSK-3 in High Fat Diet Induced Obesity and Glucose Intolerance [PDF]

open access: yesCells, 2022
Obesity-associated metabolic disorders are rising to pandemic proportions; hence, there is an urgent need to identify underlying molecular mechanisms. Glycogen synthase kinase-3 (GSK-3) signaling is highly implicated in metabolic diseases.
Manisha Gupte   +5 more
doaj   +2 more sources

Towards discovery of new leishmanicidal scaffolds able to inhibit Leishmania GSK-3 [PDF]

open access: yesJournal of Enzyme Inhibition and Medicinal Chemistry, 2020
Previous reports have validated the glycogen synthase kinase-3 (GSK-3) as a druggable target against the human protozoan parasite Leishmania. This prompted us to search for new leishmanicidal scaffolds as inhibitors of this enzyme from our in-house ...
Paula Martínez de Iturrate   +9 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy